Stay updated on ORION-01 Oregovomab & Nivolumab Clinical Trial
Sign up to get notified when there's something new on the ORION-01 Oregovomab & Nivolumab Clinical Trial page.

Latest updates to the ORION-01 Oregovomab & Nivolumab Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedMinor revision label updated from v3.3.1 to v3.3.2; core study details and eligibility information remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check21 days agoChange DetectedRevision label on the page updated from v3.2.0 to v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check29 days agoChange DetectedThe general government operating status notice on the page was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check43 days agoChange DetectedThe update shows only minor UI/formatting adjustments; there are no changes to the study data or its status.SummaryDifference0.4%

- Check71 days agoChange DetectedMajor update: version bumped to v3.2.0 with a prominent notice about funding-related access limits and where to check current operating status; previously listed v3.1.0 has been removed.SummaryDifference2%

- Check79 days agoChange DetectedCore content update: version bumped from v3.0.2 to v3.1.0; no other substantive changes indicated.SummaryDifference0.1%

Stay in the know with updates to ORION-01 Oregovomab & Nivolumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ORION-01 Oregovomab & Nivolumab Clinical Trial page.